FDA approves Enspryng for thyroid eye disease treatment

The IPO drought is driving private equity-owned companies to the debt market to pay investors

CNBC · Markets 10m ago

Exclusive-US holds more secret talks with Myanmar’s military-backed rulers in Tokyo, sources say

Investing.com · News 28m ago

Morning Bid: Calm after CoreWeave shock, but for how long?

Investing.com · News 33m ago

One Singapore ship was sunk, but here's why others are still transiting the Strait of Hormuz

CNBC · Markets 41m ago

Tech Mahindra up 7% after Q2 results, dividend, bonus shares announced- Buy, sell or hold? Check target prices, ratings

LiveMint · Markets 43m ago

IDBI Bank shares crashed after Fairfax deal; should you buy this to reap profits later? Will they rise? Experts' views

LiveMint · Markets 46m ago

Wipro shares rise 5%, up 15% so far in October - Should you buy this IT stock after Q2 results? Experts suggest

LiveMint · Markets 47m ago

Asia FX subdued, dollar weakens after bond rally; rupee set for 2% weekly jump

Investing.com · News 49m ago

Indonesia stocks suffer biggest daily slump since 1998 as MSCI weighs downgrade

Investing.com · News 52m ago

Why is Sourcenext stock sliding today?

Investing.com · News 54m ago